Skip to main content

Table 3 Primary, secondary and tertiary outcome measures

From: Protocol for a randomized comparison of integrated versus consecutive dual task practice in Parkinson’s disease: the DUALITY trial

  Outcome measures Baseline 1 Baseline 2 Post-intervention 12 week follow-up
Primary outcome measure      
DT gait performance Gait velocity Stroop x x x x
Secondary outcome measures      
DT gait performance Cadence, Stride length Stroop x x x x
Gait variability Stroop x x x x
Gait velocity, Cadence, Stride length Digit x x x x
  Gait variability Digit x x x x
Gait velocity, Cadence, Stride length Mobile x x x x
Phone     
Gait variability Mobile Phone x x x x
ST gait performance Gait velocity x x x x
Cadence x x x x
Stride length x x x x
  Gait variability measures x x x x
DT cognitive tasks Reaction time digit x x x x
  Response time digit x x x x
Errors digit x x x x
  Reaction time Stroop x x x x
Errors Stroop x x x x
  Errors Mobile phone x x x x
ST cognitive tasks Reaction time digit x x x x
  Response time digit x x x x
Errors digit x x x x
  Reaction time Stroop x x x x
Errors Stroop x x x x
  Errors Mobile phone x x x x
Tertiary outcome measures      
Adverse effects Number of falls Weekly follow-up
Motor function MDS-UPDRS III x x x x
  New FOGQ x x x x
  ABC x x x x
Cognitive function Scopa-Cog x x x x
  Alternating fluency (ANT/AIT) x x x x
FAB x - - -
Descriptors Disease duration x - - -
Medication dose x x x x
Hoehn and Yahr stage x - - -
MMSE x - - -
MoCA x - - -
Quality of life PDQ-39 x x x x
Patient experience Focus interview - - - x
  1. DT: Dual task. ST: Single task. MDS-UPDRS part III: Unified Parkinson’s Disease Rating Scale – motor part. H-Y: Hoehn and Yahr stage. New FOGQ: new Freezing of Gait Questionnaire. ABC: Activities specific Balance Confidence scale. Scopa-Cog: Scales for Outcomes in Parkinson’s disease – cognitive. ANT: Alternating Names Test. AIT: Alternating Intakes test. MMSE: Mini Mental State Examination. MoCA: Montreal Cognitive Assessment. FAB: Frontal Assessment Battery. PDQ-39: Parkinson’s Disease Quality of Life Questionnaire.